Navigation Links
BioCryst Announces Partnerships for Peramivir for Influenza Outside the U.S.
Date:9/15/2009

BIRMINGHAM, Ala., Sept. 15 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has signed binding letters of intent with three partners who will exclusively represent BioCryst and its anti-viral peramivir for influenza stockpiling opportunities, as well as for marketing and distribution of peramivir for seasonal influenza upon local regulatory approval, within their territories outside the U.S. Each partner will immediately begin meeting with key government officials in their respective territories to discuss peramivir's availability during this global health emergency.

BioCryst's new partners include:

  • moksha8 Pharmaceuticals, Inc. for Brazil and Mexico

moksha8 Pharmaceuticals, Inc. has established broad commercial operations in Brazil and Mexico, the two key countries in Latin America that represent 75% of the $30 billion Latin America pharmaceutical market. The Company is currently selling over $200 million of products in the anti-infectives, central nervous system and inflammation indications under partnerships with Roche and Pfizer. Products in the Company's portfolio include key brands such as Rocephin, Bactrim, Lexotan and Rivotril.

  • NT Pharma (Group) Co., Ltd. for China

NT Pharma was established in 1995 and has over 1,000 employees, corporate offices in Hong Kong and sales and marketing subsidiaries in Shanghai, Beijing, Guangzhou, Suzhou, Taizhou and Hainan for the distribution of pharmaceutical products including prescription medicine and vaccines. In 2009, the Group expects to achieve sales revenue of RMB 3 billion (U.S.$440 million), with a nationwide network that covers more than 100 cities, 1,500 hospital
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. BioCryst Executives to Present at Two Investor Conferences
2. BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update
3. BioCryst Pharmaceuticals Announces Presentation of Forodesine Data at the 45th Annual Meeting of the American Society of Clinical Oncology
4. BioCryst to Present at the 11th Annual BIO CEO & Investor Conference
5. BioCryst Pharmaceuticals to Announce Fourth Quarter and Year End 2008 Financial Results on February 6, 2009
6. BioCryst to Present at the Rodman and Renshaw 10th Annual Healthcare Conference
7. BioCryst Reports Positive Results From a Phase 2 Study of Intravenous Peramivir for Outpatient Influenza
8. BioCryst Pharmaceuticals to Announce First Quarter 2008 Financial Results on May 8, 2008
9. BioCryst to Release Third Quarter 2007 Financial Results on Thursday, November 8, 2007
10. avVaa World Health Care Products, Inc. Announces DRTV Test Results
11. Building Healthier America Announces the High Five Program Addressing Factors Affecting the Energy Levels of Overweight Men
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... News) -- A new Canadian study has uncovered an ... less likely than men to get trauma center care ... to health care services in general have been recognized ... disparities extend to the treatment of severe injuries in ... at Sunnybrook Health Sciences Centre and the University of ...
(Date:5/20/2013)... 2013 The International Distance Skateboard Association has ... for the best long distance skaters to attend and compete. ... a venue of raising money for our local Boys & ... IDSA is the authority on long distance races throughout the ... event is safe and organized for all who want to ...
(Date:5/20/2013)... 2013 CosmosID, a leading data mining solutions company for ... collaboration results on analysis of labeling claims for the ... , The Food and Drug Administration (FDA) and CosmosID ... probiotics, four of which have been reported at the ... tests was to compare the identity of species and ...
(Date:5/20/2013)... Dalton, Georgia (PRWEB) May 20, 2013 ... fields, has significantly expanded its presence in the Midwest ... office in Kansas City, Missouri. Sporturf Midwest is ... focus on Iowa, Nebraska, Missouri and Kansas. , ... Sporturf has not really been in before,” noted Shonk. ...
(Date:5/20/2013)... Online education provides the convenience, flexibility ... not offer. According to the American Heart Association, ... classroom learning to eLearning due to changing economic ... maximize training budgets, but it is also proven ... 25–60%. A higher retention of content is probable, ...
Breaking Medicine News(10 mins):Health News:Women Less Likely to Get Trauma Center Care After Injury: Study 2Health News:CosmosID unveils new tool for faster, specific and accurate testing of probiotics products 2Health News:Sporturf Expands into the Midwestern U.S. 2Health News:Swank HealthCare Announces New Offering of Additional American Heart Association’s Accredited Online Courses 2
... TORONTO, February 16, 2011 − One of the tough challenges ... how to parent the surviving children, and the task begins ... From the moment their child dies, parents are faced with ... loss of a child and the ongoing, daily demands from ...
... By Serena Gordon HealthDay Reporter , WEDNESDAY, ... Physicians has released new guidelines recommending that doctors not ... sugar levels in patients in medical or surgical intensive ... with diabetes and without the condition. The college recommends ...
... screening and treatment of genitourinary cancers were released today in ... February 17-19, 2011, at the Orlando World Center Marriott in ... in a media presscast (press briefing via live webcast): ... cancer death for men with low initial PSAs: A large ...
... with Alzheimer,s disease or other dementias, and their families, ... plan for the patient,s progressive loss of ability to ... physician at the San Francisco VA Medical Center and ... patient is diagnosed with Alzheimer,s disease or dementia, the ...
... Men with prostate cancer may be twice as likely to have ... 20 than those without prostate cancer, a new French study suggests. ... 40s do not appear to face a similar boost in prostate ... do not face a higher risk of developing the cancer at ...
... , TUESDAY, Feb. 15 (HealthDay News) -- A review of ... Americans pop at the first sign of a cold may, in ... conducted by a team in India and published in the ... people have to stay away from work or school. "This ...
Cached Medicine News:Health News:Parenting after the death of a child a difficult balancing act: York U study 2Health News:In-Hospital Blood Sugar Levels Should Be Higher: Report 2Health News:In-Hospital Blood Sugar Levels Should Be Higher: Report 3Health News:Research presented at 2011 GU Cancers Symposium highlights advances in treatment of prostate cancer 2Health News:Financial planning a key but neglected component of Alzheimer's care, say researchers 2Health News:Could Hair Loss at 20 Signal Higher Prostate Cancer Risk? 2Health News:Could Hair Loss at 20 Signal Higher Prostate Cancer Risk? 3Health News:Zinc May Help Ease Common Cold: Analysis 2
(Date:5/17/2013)... 17, 2013 Medical devices are any medical ... product. In light of their different mechanisms, actions and ... more complicated than drug trails due to their unique ... instead of evaluating both safety and efficacy (which is ... is the same as the SFDA) evaluate MDs for ...
(Date:5/17/2013)... DIEGO , May 17, 2013  Sorrento ... that its Fast-Track Advanced Technology Small Business Technology ... Institute of Allergy and Infectious Diseases (NIAID), a ... supporting the development of novel human antibody therapeutics ... aureus or Staph) infections, including methicillin-resistant ...
(Date:5/17/2013)... , May 17, 2013  Technology advances ... communicate internally. Faced with a constantly evolving communication ... and tactics for communicating with internal executives. It ... all the strategies, tactics and tools that are ... In a new study, Best Practices, LLC explores ...
Breaking Medicine Technology:Statistical Challenges in Medical Device Trail Evaluation 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2
... VANCOUVER, British Columbia, June 21, 2011 Enox Biopharma, Inc. ... East Investment in Innovation Conference on Wednesday, June 22 at ... Hyatt Regency Hotel in Boston. The IN3 ... and networking meeting. The meeting is designed to provide exposure ...
... Robbins & Myers, Inc. (NYSE: RBN ... approved its regular quarterly cash dividend payment of $0.045 ... 2011 to shareholders of record as of July 8, ... leading supplier of engineered equipment and systems for critical ...
Cached Medicine Technology:Enox Biopharma, Inc. Will Present at IN3 East Investment in Innovation Conference 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: